Infectious Diseases Research and Development Act of 2005

[AI summary unavailable — showing source text] Infectious Diseases Research and Development Act of 2005 - Limits the liability of manufacturers of qualified infectious disease products by limiting: (1) punitive damages unless the manufacturer acted with malicious intent to injure the individual or deliberately failed to avoid unnecessary injury that the manufacturer knew the individual was substantially certain to suffer; and (2) non-economic damages to $250,000. Sets forth circumstances under which the term of a patent may be extended for qualified infectious disease products. Requires the Secretary of Health and Human Services to designate qualified infectious disease products as fast-track products for approval. Amends the Public Health Service Act to require the Director of the National Institute of Allergy and Infectious Diseases to expand and intensify efforts to assist small manufacturers to conduct end-stage clinical trials on qualified infectious disease products. Amends the Internal Revenue Code to establish an infectious disease research credit and a qualified infectious disease products manufacturing facilities investment credit. Authorizes appropriations for activities related to antimicrobial resistance. Establish…